Coronary Heart Disease Prevention
Coronary Heart Disease Prevention
A stent treats one segment of one artery, and a bypass routes around three; neither touches the process that built the plaque. That process — the LDL, the blood pressure, the blood sugar, the smoke — is what secondary prevention treats, and it is treated forever rather than once. This is the least dramatic part of coronary care and the part with the largest effect on whether the next decade is quiet: a set of targets, four or five medicines, a rehabilitation programme, and a follow-up rhythm that continues after the flight home.
The four numbers the plan is built around
Secondary prevention is, in practice, the management of four numbers and one habit. Each has a target, the target is set with the cardiologist rather than read off a laboratory form, and progress is tracked at every review:
| Target | What the plan does | Why it holds the disease still |
|---|---|---|
| LDL cholesterol | A statin, intensified where needed with additional lipid therapy, to reach the target set for a patient after a diagnosis — which sits below the general population's reference range, and lower again for the highest-risk patients | The raw material of plaque; the factor with the strongest evidence that lowering it lowers events |
| Blood pressure | Measured properly at home as well as in clinic, treated with the ACE-inhibitor or ARB and beta blocker already in the foundation, adjusted until the readings are consistently on target | Removes the mechanical injury that starts the plaque and stresses the heart between events |
| Diabetes control | Coordinated with the diabetes treatment, including the newer therapies with proven cardiac benefit; the HbA1c is part of every cardiac review | Slows the wall injury and the lipid pattern that accelerate plaque — and diabetic patients carry the least reliable warning system |
| Smoking status | Cessation support as a treatment, not as advice — including pharmacological help where wanted | The fastest-moving lever: event risk begins to fall within months of stopping, at every age and after every diagnosis |
The medicines that protect, and the two honest rules about them
Prevention's medicines are the foundation described on the treatment page — antiplatelet therapy, statin, blood-pressure control — and they generate the same two questions from almost every patient. The first: "I feel completely well — do I still need them?" Yes, and this is the single most consequential adherence point in the whole disease: the medicines work silently, the plaques they stabilise are silent, and the first symptom of stopping them is often the event they were preventing. The second: "Will I be on them forever?" Usually most of them, at doses that fall as the risk factors improve — the dose follows the numbers, the protection does not. Medication is reviewed at every visit, and doses are changed from measurements rather than from how the chest feels.
Cardiac rehabilitation: capacity rebuilt under supervision
Exercise after a cardiac diagnosis is treatment, and like all treatment it has a dose and a progression. A structured cardiac rehabilitation programme builds capacity with graded exercise under monitoring, teaches the risk-factor plan, addresses the depression and anxiety that follow cardiac events more often than patients expect, and stages the return to work, travel and the activities the patient actually cares about. Our Foshan hospital holds a national cardiac rehabilitation certification; international patients receive the exercise prescription and the staged plan to continue at home, with remote follow-up — the programme is a bridge, not a place.
Diet, activity and the rest of the day
- Movement as prescription: regular aerobic activity — walking is entirely legitimate — built up progressively; the rehabilitation programme sets the dose, and the habit keeps it.
- The dietary pattern that has the evidence is Mediterranean-style: vegetables, legumes, fish, olive oil, nuts; the pattern matters more than any single food, and the plan is easier to keep than to restart.
- Weight and waist as part of the diabetes and blood-pressure plan rather than as an end in themselves.
- Alcohol within limits, and less is better; sleep as a genuine risk factor — untreated sleep apnoea works against both the blood pressure and the rhythm.
- Illness planning: influenza vaccination is part of cardiac secondary prevention in most guidelines — a recommendation that surprises patients until the first winter explains it.
Follow-up: what is reviewed, and how often
The rhythm is set by the treatment received and settles into a pattern over the first year: early reviews after a procedure or an acute event — medication tolerance, wound care, the antiplatelet plan — then progressively longer intervals in which the review is of the numbers and the symptoms: the lipid panel, blood pressure and diabetes control against their targets, and any return or change of chest symptoms, breathlessness or exercise capacity. Testing is repeated when the symptoms ask for it rather than on a calendar; the risk-factor numbers, by contrast, are measured on a schedule, because they drift silently. For international patients the reviews continue remotely, and the threshold for returning is agreed before the flight home rather than improvised afterwards.
A plan that fits on one page
Everything on this page compresses to five lines a patient can keep — and patients who can recite their plan do better than patients who carry it in a folder:
- My numbers: the LDL, blood pressure and diabetes targets, written down, with the date of the last check.
- My medicines: what each one is for — because the tablet taken knowingly is the tablet that gets taken.
- My activity: the exercise prescription and what progression is expected.
- My warning signs: which sensations are routine and which mean emergency help — the symptoms page in three lines.
- My next review: when, with what tests, and who to contact between reviews.